Comment

  • 12 January 2018

    Vertex prepares to bolster pipeline portfolio

    Pavan Kottamasu, GlobalData Healthcare & Pharmaceutical Analyst Jeffrey Leiden, M.D., Ph.D., Chairman, President, and CEO of Vertex Pharmaceuticals, took the stage on Day 1 of the 2018 J.P. Morgan (JPM)...

  • 3 January 2018

    Phase I trials on the rise in New Zealand

    GlobalData has compiled a summary of clinical trials in New Zealand. GlobalData captured records of 1,016 clinical trials across all diseases and phases that had a start date between 1...